Literature DB >> 22608669

Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?

Bobbi Fleiss1, Pierre Gressens.   

Abstract

Cerebral palsy is caused by injury or developmental disturbances to the immature brain and leads to substantial motor, cognitive, and learning deficits. In addition to developmental disruption associated with the initial insult to the immature brain, injury processes can persist for many months or years. We suggest that these tertiary mechanisms of damage might include persistent inflammation and epigenetic changes. We propose that these processes are implicit in prevention of endogenous repair and regeneration and predispose patients to development of future cognitive dysfunction and sensitisation to further injury. We suggest that treatment of tertiary mechanisms of damage might be possible by various means, including preventing the repressive effects of microglia and astrocyte over-activation, recapitulating developmentally permissive epigenetic conditions, and using cell therapies to stimulate repair and regeneration Recognition of tertiary mechanisms of damage might be the first step in a complex translational task to tailor safe and effective therapies that can be used to treat the already developmentally disrupted brain long after an insult.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22608669     DOI: 10.1016/S1474-4422(12)70058-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  108 in total

1.  Neuroregenerative and protective functions of Leukemia Inhibitory Factor in perinatal hypoxic-ischemic brain injury.

Authors:  Jie Lin; Yusuke Niimi; Mariano Guardia Clausi; Hur Dolunay Kanal; Steven W Levison
Journal:  Exp Neurol       Date:  2020-04-19       Impact factor: 5.330

Review 2.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 3.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

4.  Neutrophil and monocyte toll-like receptor 4, CD11b and reactive oxygen intermediates, and neuroimaging outcomes in preterm infants.

Authors:  Fiona M O'Hare; William Watson; Amanda O'Neill; Tim Grant; Chike Onwuneme; Veronica Donoghue; Eoghan Mooney; Paul Downey; John Murphy; Anne Twomey; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2015-03-31       Impact factor: 3.756

5.  The Paradoxical Effects of Chronic Intra-Amniotic Ureaplasma parvum Exposure on Ovine Fetal Brain Development.

Authors:  Ruth Gussenhoven; Daan R M G Ophelders; Matthew W Kemp; Matthew S Payne; Owen B Spiller; Michael L Beeton; Sarah J Stock; Bertha Cillero-Pastor; Florian P Y Barré; Ron M A Heeren; Lilian Kessels; Bas Stevens; Bart P Rutten; Suhas G Kallapur; Alan H Jobe; Boris W Kramer; Tim G A M Wolfs
Journal:  Dev Neurosci       Date:  2017-08-29       Impact factor: 2.984

6.  The Long-Term Impairment in Redox Homeostasis Observed in the Hippocampus of Rats Subjected to Global Perinatal Asphyxia (PA) Implies Changes in Glutathione-Dependent Antioxidant Enzymes and TIGAR-Dependent Shift Towards the Pentose Phosphate Pathways: Effect of Nicotinamide.

Authors:  C Lespay-Rebolledo; A Tapia-Bustos; D Bustamante; P Morales; M Herrera-Marschitz
Journal:  Neurotox Res       Date:  2019-06-11       Impact factor: 3.911

7.  Long-Term Neuropathological Changes Associated with Cerebral Palsy in a Nonhuman Primate Model of Hypoxic-Ischemic Encephalopathy.

Authors:  Ryan M McAdams; Bobbi Fleiss; Christopher Traudt; Leslie Schwendimann; Jessica M Snyder; Robin L Haynes; Niranjana Natarajan; Pierre Gressens; Sandra E Juul
Journal:  Dev Neurosci       Date:  2017-05-10       Impact factor: 2.984

Review 8.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 9.  Pharmacologic neuroprotective strategies in neonatal brain injury.

Authors:  Sandra E Juul; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

10.  Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia.

Authors:  Sina Falahati; Markus Breu; Adam T Waickman; Andre W Phillips; Edwin J Arauz; Sophie Snyder; Michael Porambo; Katharina Goeral; Anne M Comi; Mary Ann Wilson; Michael V Johnston; Ali Fatemi
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.